In the treatment of aortic aneurysms, these nanoparticles deliver elastin-stimulating agents to the aneurysm site, promoting the regeneration of elastin fibers and restoring structural integrity to the vessel wall [108]. The gene discussed is ELN; the disease is aortic aneurysm.